Critical Path Public Private Partnerships Clinical Trials Optional
Department of Health and Human Services
Description
The FDA is seeking applications to continue maintaining and managing existing consortia groups established by the Critical Path Institute. This is a renewal of a cooperative agreement under the Critical Path Initiative to support innovative, collaborative projects focused on research, education, and outreach. The aim is to foster drug product innovation, accelerate development and manufacturing, and enhance the safety, efficacy, quality, and performance of therapeutics. Funding will be provi…
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Show More
Source
Grant ID
FOR-FD-24-012
Agency
Department of Health and Human Services
Subcategory/Subagency
Food and Drug Administration
Eligibility
The following categories of applicants are invited to apply:
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Awards & Funding
Award Ceiling
$20M
Award Floor
$20M
Funding Amount
Discretionary
Links
Similar opportunities
- Collaborations to Enhance Drug Development and Regulatory Science
Department of Health and Human Services
- Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)
Department of Health and Human Services
- Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for substance use disorders (SUDs) (U54 - Clinical Trials Not Allowed)
Department of Health and Human Services
- Forecast to Publish a Notice of Funding Opportunity for The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratory (U24 Clinical Trial Not Allowed)
Department of Health and Human Services
- Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed)
Department of Health and Human Services